F-10: Ayr Wellness Files US$250 Million Shelf Prospectus, Paving Way for Future Offerings

Ayr Wellness Inc. has filed a preliminary short form base shelf prospectus for up to US$250 million, allowing the company to offer various securities over the next 25 months.

Summary

• Ayr Wellness Inc. has filed a preliminary short form base shelf prospectus to offer up to US$250 million of securities.
• The securities may include subordinate voting shares, restricted voting shares, limited voting shares, warrants, subscription receipts, debt securities, convertible securities, and units.
• The company may offer these securities separately or in combination over a 25-month period.
• The prospectus also allows for at-the-market distributions, though the company has not yet engaged an investment dealer for such a program.
• The company intends to wind-up AYR Wellness Canada in the near future, pursuant to which all of the assets and liabilities of AYR Wellness Canada, including the 2026 Notes, will become the assets and liabilities of the Company.
• As a result of the Arrangement and related, previously disclosed transactions, the Company has retired or extended the maturity of nearly $400 million in debt in the past year and now has limited debt maturities until 2026.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily outlining the details of the shelf prospectus and related legal and regulatory matters. The potential for capital raising is a positive, but the inherent risks of the cannabis industry and regulatory uncertainties temper the overall sentiment.

Positives

• The shelf prospectus provides Ayr Wellness with flexibility to raise capital in the future.
• The company has retired or extended the maturity of nearly $400 million in debt in the past year and now has limited debt maturities until 2026.
• The company has a diverse portfolio of cannabis assets in multiple states.

Negatives

• The cannabis industry is illegal under U.S. federal law, posing significant risks to Ayr Wellness.
• The company may face heightened scrutiny by regulators due to its involvement in the U.S. cannabis market.
• The company faces significant risks for operating in an industry that is illegal under U.S. federal law, including the risk of potential enforcement of such federal laws against AYR or its affiliates.

Risks

• The U.S. federal government could enforce laws against cannabis, impacting Ayr Wellness's operations.
• Banks may be hesitant to provide financial services to cannabis businesses, leading to cash-heavy operations.
• Changes in government policy or public opinion could negatively affect the cannabis industry.
• The company may face difficulties in accessing public and private capital.
• The company's licenses may not be renewed in a timely manner.
• The company is subject to the limits of Section 280E of the United States Internal Revenue Code.

Future Outlook

Ayr Wellness intends to use the net proceeds from any offering of Securities for general corporate purposes, capital projects, potential future acquisitions, and internal expansion.

Industry Context

The announcement comes as cannabis companies are seeking financial flexibility amid evolving regulatory landscapes and market conditions in the U.S. and Canada. The ability to raise capital through various means is crucial for growth and strategic initiatives in this sector.

Comparison to Industry Standards

• Other cannabis companies, such as Curaleaf, Trulieve, and Green Thumb Industries, have also utilized shelf prospectuses to raise capital.
• The size of the offering (up to US$250 million) is comparable to other shelf prospectuses filed by major players in the cannabis industry.
• The inclusion of various types of securities (equity, debt, and hybrid instruments) is a common practice to attract a wider range of investors.

Management Changes

Legal Proceedings

• FTI Capital Advisors Canada ULC has commenced a claim against the Company in the Ontario Superior Court of Justice seeking fees in respect of a number of financing transactions in respect of which FTI had no involvement.
• The Company is strenuously defending the proceedings vigorously and has denied liability to FTI.

Stakeholder Impact

• Shareholders may experience dilution if the company issues new equity securities.
• The company's ability to raise capital could support future growth and job creation.
• Customers may benefit from the company's ability to invest in product development and improved services.

Next Steps

• Ayr Wellness may issue prospectus supplements to offer specific securities under the shelf prospectus.
• The company may engage an investment dealer for at-the-market distributions.
• The company intends to wind-up AYR Wellness Canada in the near future, pursuant to which all of the assets and liabilities of AYR Wellness Canada, including the 2026 Notes, will become the assets and liabilities of the Company.

Key Dates

Keywords

Ayr Wellness, shelf prospectus, securities, cannabis, capital raise, debt restructuring, U.S. federal law, regulations, offerings, licenses